Thc Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended April 30, 2021
June 22, 2021 at 06:03 am EDT
Share
THC Therapeutics, Inc. announced earnings results for the third quarter ended April 30, 2021. For the third quarter, the company announced operating loss was USD 169,508 compared to USD 511,071 a year ago. Net loss was USD 350,780 compared to USD 1.260 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.09 a year ago. For the nine months, operating loss was USD 611,464 compared to USD 1.078 million a year ago. Net loss was USD 800,655 compared to USD 2.272 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.15 a year ago.
THC Therapeutics, Inc. is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also reduce the bacterial count of the cannabis during the drying process. The Company operates in the wellness industry.
THC THERAPEUTICS, INC. 
